openPR Logo
Press release

Gonorrhoea Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Evofem Biosciences, GlaxoSmithKline, Entasis, Alopexx, Nobelex, Summit Therapeutics, TherapyX, AchilleS Vaccines, Recce Pharma, VenatoRx

08-28-2023 07:16 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Gonorrhoea Pipeline Assessment (2023) Covering Clinical

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Gonorrhoea therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Gonorrhoea Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Gonorrhoea Therapeutics Market.

The report provides a detailed description of the Gonorrhoea drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Gonorrhoea Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gonorrhoea Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Gonorrhoea therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gonorrhoea treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Gonorrhoea drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Gonorrhoea treatment market.

Learn More about the Clinical and Commercial Development Activities in the Gonorrhoea Therapeutics Domain:
https://www.delveinsight.com/report-store/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Gonorrhoea Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Gonorrhoea pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Request for Sample PDF to Understand More About the Gonorrhoea Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Gonorrhoea Therapeutics Analysis
Gonorrhea can lead to serious health complications if left untreated, including pelvic inflammatory disease (PID) in women, which can result in infertility or ectopic pregnancies. It can also increase the risk of acquiring or transmitting HIV. Treatment for gonorrhea typically involves antibiotics to eliminate the bacterial infection. However, due to the increasing prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae, treatment protocols change over time.

There are approx. 12+ key companies developing therapies for Gonorrhoea. Currently, GlaxoSmithKline is leading the therapeutics market with its Gonorrhoea drug candidates in the most advanced stage of clinical development.

Gonorrhoea Companies in the Therapeutics Market Include:
• Evofem Biosciences
• GlaxoSmithKline
• Entasis Therapeutics
• Alopexx Pharmaceuticals
• Nobelex Biotech
• Summit Therapeutics
• TherapyX
• AchilleS Vaccines
• Recce Pharmaceuticals
• VenatoRx Pharmaceuticals
And many others

Emerging and Marketed Gonorrhoea Therapies Covered in the Report Include:
• Gepotidacin: GlaxoSmithKline
• Zoliflodacin: Entasis Therapeutics
• SMT-571: Summit Therapeutics
• F 598: Alopexx Pharmaceuticals
• EVO100: Evofem Biosciences
• ETX-0914: Entasis Therapeutics
And many more

Get an in-depth Assessment of the Emerging Therapies and Gonorrhoea Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Gonorrhoea Current Treatment Patterns
4. Gonorrhoea - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Gonorrhoea Late-Stage Products (Phase-III)
7. Gonorrhoea Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Gonorrhoea Discontinued Products
13. Gonorrhoea Product Profiles
14. Gonorrhoea Companies
15. Gonorrhoea Drugs
16. Dormant and Discontinued Products
17. Gonorrhoea Unmet Needs
18. Gonorrhoea Future Perspectives
19. Gonorrhoea Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/gonorrhoea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Healthcare Consulting and Competitive Intelligence Services by DelveInsight
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Functional Electrical Stimulation (FES) Devices Market
https://www.delveinsight.com/report-store/functional-electrical-stimulation-fes-devices-market

Hypoactive Sexual Desire Disorder Market
https://www.delveinsight.com/report-store/hypoactive-sexual-desire-disorder-hsdd-market

Complicated Intra-Abdominal Infections Market
https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market

Malignant Pleural Mesothelioma (MPM) Market
https://www.delveinsight.com/report-store/malignant-pleural-mesothelioma-market

Mitochondrial Myopathies Market
https://www.delveinsight.com/report-store/mitochondrial-myopathies-market

Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market

Mayus Kinase (jak) Inhibitors Market
https://www.delveinsight.com/report-store/mayus-kinase-inhibitors-market

Acute Heart Failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market

Bacterial Vaginosis Market
https://www.delveinsight.com/report-store/bacterial-vaginosis-market

Hyperphosphatemia Market
https://www.delveinsight.com/report-store/hyperphosphatemia-market

Pleural Effusion Market
https://www.delveinsight.com/report-store/pleural-effusion-market

Epidermolysis Bullosa Market
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market

Gestational Diabetes Market
https://www.delveinsight.com/report-store/gestational-diabetes-market

Intratumoral Cancer Therapies Market
https://www.delveinsight.com/report-store/intratumoral-cancer-therapies-market

Wasting Syndrome Market
https://www.delveinsight.com/report-store/wasting-syndrome-market

Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market

Vagus Nerve Stimulator (VNS) Global Market
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market

Abetalipoproteinemia Market
https://www.delveinsight.com/report-store/abetalipoproteinemia-market

Myelofibrosis (MF) Market
https://www.delveinsight.com/report-store/myelofibrosis-mf-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Homozygous Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market

Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market

West Nile Encephalitis Market
https://www.delveinsight.com/report-store/west-nile-encephalitis-market

Gonorrhea Market
https://www.delveinsight.com/report-store/gonorrhea-market

Polymyositis Market
https://www.delveinsight.com/report-store/polymyositis-market

Subarachnoid Hemorrhage Market
https://www.delveinsight.com/report-store/subarachnoid-hemorrhage-market

Acute Pancreatitis Market
https://www.delveinsight.com/report-store/acute-pancreatitis-market

Acute Respiratory Distress Syndrome (ARDS) Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market

PARP Inhibitors Market
https://www.delveinsight.com/report-store/parp-inhibitors-competitive-landscape-pipeline-and-market-analysis

Bacterial Conjunctivitis Market
https://www.delveinsight.com/report-store/bacterial-conjunctivitis-market

Desmoplastic Small Round Cell Tumors (DSRCTS) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market

Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market

Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market

Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market

PCSK9 Inhibitors Market
https://www.delveinsight.com/report-store/pcsk9-inhibitors-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Dravet Syndrome Market
https://www.delveinsight.com/report-store/dravet-syndrome-market

Genital Warts Market
https://www.delveinsight.com/report-store/genital-warts-condyloma-acuminatum-market

Orthopedic Trauma Devices Market
https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market

Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market

Erythema Market
https://www.delveinsight.com/report-store/erythema-market

Primary Open Angle Glaucoma (POAG) Market
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market

Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market
https://www.delveinsight.com/report-store/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market

Traumatic Brain Injury Assessment Devices Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-assessment-management-devices-market

Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market

Hormone Sensitive Advanced Prostate Cancer Market
https://www.delveinsight.com/report-store/hormone-sensitive-advanced-prostate-cancer-market

Neuromodulation Devices Global Market
https://www.delveinsight.com/report-store/neuromodulation-devices-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gonorrhoea Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Evofem Biosciences, GlaxoSmithKline, Entasis, Alopexx, Nobelex, Summit Therapeutics, TherapyX, AchilleS Vaccines, Recce Pharma, VenatoRx here

News-ID: 3185076 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Gonorrhoea

CT/NG Testing Market Projected to Grow at 8.1% CAGR, Surpassing USD 3.2 Billion …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CT/NG Testing Market- (By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User (Diagnostics & Laboratories, Hospitals & Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global CT/NG Testing Market is valued at US$
CT/NG Testing Market Projected to Grow at 8.1% CAGR, Surpassing USD 3.2 Billion …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CT/NG Testing Market- (By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User (Diagnostics & Laboratories, Hospitals & Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global CT/NG Testing Market is valued at US$
Gonorrhea Treatment Market Size, Share, Report and Forecast 2024-2032
Gonorrhea Treatment Market Outlook The gonorrhea treatment market was estimated to be worth USD 1.48 billion in 2023. The market is likely to grow at a rate of 4.7% in the forecasted period 2024-2032. Within this growth rate, the market value is estimated to reach about USD 2.24 billion by 2032. The market is primarily driven by the increased prevalence of sexually transmitted infections and the expected launch of novel therapies. Gonorrhea
Gonorrhea Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Gonorrhea therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Gonorrhea Pipeline Insight, 2023" report by DelveInsight
CT/NG Testing Market - Know the Untapped Revenue Growth Opportunities
CT/NG Testing Market worth $3.27 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CT/NG Testing Market- (By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User (Diagnostics & Laboratories, Hospitals & Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to
Gonorrhoea Market Size was approximately USD XX Million in 2022, estimates Delve …
"The Gonorrhoea Market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Gonorrhoea pipeline products will significantly revolutionize the Gonorrhoea market dynamics" The Gonorrhoea market report provides current treatment practices, Gonorrhoea emerging drugs, market share of individual therapies, and current and forecasted 7MM a Gonorrhoea market size from 2019 to 2032. The report also covers current Gonorrhoea treatment